Updates

Categories
  1. New immunotherapy shows reduction in tumor size for NSCLC patients

    Industry NewsIt’s believed that this immunotherapy and its dual approach to fighting cancer will be a notable complement to existing immuno-oncology treatments.

    Read more »
  2. Response to Keytruda (pembrolizumab) better in older patients, study suggests

    Industry NewsResearchers believe these differences are due to a reduced immunosuppressive tumor environment in older patients.

    Read more »
  3. T-cell therapy yields objective response rate of 52% in lymphoma (DLBCL) patients

    Industry NewsThe 52% (95% CI, 41-62) ORR included a complete response rate of 40% and a partial response rate of 12%.

    Read more »
  4. Keytruda-chemo combination shows beneficial response in treating metastatic NSCLC

    Industry NewsResearchers say the addition of Keytruda (pembrolizumab) in this study almost doubled the response rate of chemo for patients with NSCLC.

    Read more »
  5. New study suggests men and women may benefit differently from some immunotherapy medications

    News updateThe study showed that the relative survival gain almost doubled in men, compared to female patients, regardless of the type of cancer and drugs given.

    Read more »
  6. All about erenumab (Aimovig): the unique new migraine treatment

    A new preventive migraine treatment, Aimovig (erenumab-aooe), poses promising possibilities for some migraine sufferers.

    Aimovig

    Read more »
  7. Imfinzi may offer patients benefits in earlier stages of lung cancer

    Industry NewsNew clinical results show that Durvalumab improved survival (versus a placebo) in patients with non–small cell lung cancer.

    Read more »
  8. New relief for migraine patients?

    News updateThe first-ever preventative treatment for migraine in adults, Aimovig (erenumab-aooe) is now approved by the Food and Drug Administration.

    Read more »
  9. Patients struggling with withdrawal symptoms may find new relief

    Industry NewsLucemyra (lofexidine hydrochloride), now approved by the Food and Drug Administration, may offer relief (and new hope) for patients experiencing withdrawal symptoms from opioid dependence.

    Read more »
  10. Mayo Clinic researchers make further step to a DNA test for liver cancer

    "We currently test for liver cancer using ultrasound and a blood protein marker called alpha fetoprotein," says John Kisiel, M.D., a gastroenterologist at Mayo Clinic. "Unfortunately, these tests are not very sensitive for curable stage liver cancers, and most patients who need this testing do not have it easily available or [are] not able to receive it often enough to be effective." The new advance by the team opens the door to further development of a DNA test. 

    New on a screen

    Read more »
  11. Genetic diversity could help protect against disease

    A team of researchers from the Leibniz-Institute of Freshwater Ecology and Inland Fisheries (IGB) has succeeded in demonstrating experimentally (in a lab) that genetic diversity makes populations more resistant to disease.

    Industry News 

    Read more »
  12. Ingestible 'bacteria on a chip' could help diagnose disease

    Researchers have built an ingestible sensor equipped with genetically engineered bacteria that can diagnose bleeding in the stomach or other gastrointestinal problems. Ultra-low-power sensors carrying genetically engineered bacteria can detect gastric bleeding. 

    Industry News 

    Read more »
  13. New study shows promise of permethrin-treated clothing

    The Entomological Society of America reports today that a new study from the CDC (Centre for Disease Control) in the USA shows that permethrin-treated clothing may stop ticks from biting. This will thus reduce transmission of diseases like Lyme disease. Lab tests showed germ-carrying ticks can't move properly after contact with treated garments, making them sluggish and likely interfering with their ability to bite. 

    Industry News

     

    Read more »
  14. Lower prices negotiated for 9 medicines

    Service Announcement for price changes to 12 medicines. For 9 medicines we have negotiated lower prices for patients, 3 medicines have increases. 

    TheSocialMedwork service online 

    Read more »
  15. Ovarian cancer

    A personalised vaccine which boosts a patient’s own immune system has nearly doubled the number of women surviving ovarian cancer by two years.

    ovarian cancer

    Read more »
  16. Lung cancer

    Following an earlier negative decision, NICE is now recommending NHS use of Roche’s immunotherapy Tecentriq for lung cancer.

    lung cancer

    Read more »
  17. Leukemia

    CLL expert explains latest treatment developments in the field.
    leukemia

    Read more »
  18. Prostate cancer

    Expert emphasises healthy lifestyle in prostate cancer care.
    Industry news

    Read more »
  19. Leukemia

    Kymriah, the first FDA-approved CAR-T cell therapy, is showing promising results in treating children with acute lymphoblastic leukemia.
    leukemia

    Read more »
  20. Thyroid cancer

    The UK institute NICE gives 3 nods in thyroid cancer: Cometriq (cabozantinib), Nexavar (sorafenib) and Lenvima (lenvatinib).
    thyroid cancer

    Read more »
  21. New prices negotiated! Reductions for 38 products

    Price decreases for 38 medicines

    Read more »
  22. Leukemia

    In a recent trial, 80% of patients with (MRD)-positive acute lymphoblastic leukemia (ALL) who were treated with a drug called Blincyto (blinatumomab) achieved a complete response.
    Industry news

    Read more »
  23. Oncology

    Scientists experimenting with an innovative treatment for cancer have now devised a targeted injection that has already successfully eliminated tumours in mice.
    Industry news

    Read more »
  24. Immunotherapy

    The first ever patient to be treated with a new type of CAR-T cell therapy in a novel clinical trial is now in remission.
    Industry news

    Read more »
  25. New microneedle product could help people with ALS, MS and diabetes

    Remember the hypospray from Star Trek? Maybe it's close to reality.

    Star Trek magazine cover

    Read more »
  26. Breast cancer

    A new combination of medicines is showing positive results in ER/HER2-Positive breast cancer.
    Industry news

    Read more »
  27. New medicines coming soon!

    A list of medicines TheSocialMedwork will soon be making available.

    New medicines

    Read more »
  28. Ovarian cancer

    New test detects ovarian and 7 other cancers using simple blood sample.
    Industry news

    Read more »
  29. Breast cancer

    Lynparza (olaparib) is the first PARP inhibitor approved to treat breast cancer, and the first medicine ever for metastatic breast cancer who have a “BRCA” gene mutation.
    Industry news

    Read more »
  30. Kidney cancer

    A new study found that cabozantinib (Cabometyx) was more effective than everolimus in advanced renal cell carcinoma and bone metastases.
    kidney cancer

    Read more »
Page